Add Company
Join Now

Bryleos Revenue and Competitors

License our Company Data API

Johnson City, TN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bryleos's estimated annual revenue is currently $465k per year.(i)
  • Bryleos's estimated revenue per employee is $77,500

Employee Data

  • Bryleos has 6 Employees.(i)
  • Bryleos grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$5M3214%N/AN/A
#3
$3.6M235%N/AN/A
#4
$1.1M7-22%N/AN/A
#5
$1.7M110%N/AN/A
#6
$0.8M50%N/AN/A
#7
$6M3950%N/AN/A
#8
$0.9M60%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$1.9M120%N/AN/A
Add Company

What Is Bryleos?

Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders. \n\nIn 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.\n\nBryleos: More Life While Living

keywords:N/A

N/A

Total Funding

6

Number of Employees

$465k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M929%N/A
#2
$0.9M9-65%N/A
#3
$0.9M100%N/A
#4
$1M110%N/A
#5
$2.1M12-68%N/A